Hosted on MSN

Precision BioSciences reports encouraging muscle improvements in preclinical DMD gene therapy study

Precision BioSciences Inc. (NASDAQ:DTIL) presented new preclinical findings for its PBGENE-DMD gene therapy at the Muscular Dystrophy Association Clinical & Scientific Conference 2026 held in Orlando, ...
Hosted on MSN

Bonn team links faulty cell recycling to severe muscle disease

Researchers at the University Hospital Bonn have developed a humanized mouse model for myofibrillar myopathy type 6 (MFM6), revealing that impaired autophagy driven by a defective BAG3 protein leads ...